OPPapers.com Essay Index >> Miscellaneous >> Gene One Problem Solution
We have many free term papers and essays on Gene One Problem Solution. We also have a wide variety of research papers and book reports available to you for free. You can browse our collection of term papers or use our search engine.
Gene One Problem Solution. Running head: PROBLEM SOLUTION: GENEONE Problem
Solution: Gene One University of Phoenix March 26, 2007 ...
Gene One Problem Solution. Problem Solutions: Gene One Corporation University
of Phoenix Transformational Leadership (MBA 520) Problem ...
Gene one Problem Solution. Situation Analysis and Problem Statement Genetic
engineering involves the insertion of a segment of DNA ...
Gene One Problem Solution. Problem Solution: Gene One To adapt and change
or to remain as created is a decision many privately owned ...
Gene One Problem Solution. Problem Solution: Gene One Wall Street was showing
a growing interest in the biotech industry. Gene One ...
Submitted by terri8827 on January 15, 2008
Category: Miscellaneous
Words: 5892 | Pages: 24
Views: 402
Popularity Rank: 21,980
Average Member Grade: N/A (Add a Comment / Grade this Paper)
Running head: PROBLEM SOLUTION: GENEONE
Problem Solution: GeneOne
Terri P. Johnson
University of Phoenix
Problem Solution: GeneOne
GeneOne is a biotechnological company that has successfully increased its profits from $2 million to $400 million within eight years. The company needs to expand its operation to meet the demands and realize its annual growth targets of 40 percent. GeneOne plans to become a public initial offering (IPO) public entity. The profits from marketed stocks will be used to increase annual growth, and fund research new technologies and products. Becoming an initial public offering entity is a risky investment. No one at Gene One has experience or knowledge to implement the IPO process. Another issue to address is where the company will prove to Wall Street that it has the leadership and organizational capabilities to sustain its market shares. GeneOne’s research has become stagnant and very interdependent on one person, Teri Roberts, to develop all new technology and products. GeneOne will have to address these problems to successfully become one of the top industrial companies in the biotechnology field.
Situation Analysis
Issue and Opportunity Identification
GeneOne entered the biotechnology field in 1996, and has grown into a $400 million company in eight years. Wall Street stock investors have shown a growing interest in biotechnology, especially with new leadership at the Food and Drug Administration. GeneOne CEO and Board members believe to keep up with demand and realize annual growth targets of 40 percent, the company will have to become a public entity.
GeneOne’s founder and CEO, Don Ruiz, has a visionary goal is to sell stock publicly through the initial public offering (IPO) to obtain...
You must Login to view the entire paper.
If you are not a member yet, Sign Up for free!